This Issue At A Glance
A study by Campochiaro et al (p. 795) assessing the relationship of blocking vascular endothelial growth factor (VEGF) on progression of retinal nonperfusion (RNP) in patients with macular edema due to central retinal vein occlusion (CRVO) or branch retinal vein occlusion (BRVO) yielded a new insight: high levels of VEGF contribute to the progression of RNP, as evidenced by a reduction in progression by ranibizumab (RBZ) injections. Investigators studied data from 2 randomized phase III RBZ trials. At the month 6 primary endpoint, the percentage of patients with CRVO and (Read more...)